Dr. Ankit Anand, MD

Dr. Anand practices at San Juan Oncology Associates in Farmington, New Mexico.

Dr. Anand's NPI, 1225383359, was assigned on July 15, 2012. Dr. Anand holds New Mexico license MD2017-0984.

Dr. Anand's primary practice is San Juan Oncology Associates, at 2325 E 30th St, Farmington, NM 87401 in San Juan County. The practice phone is (505) 564-6850.

Dr. Anand's primary practice is San Juan Oncology Associates in Farmington, New Mexico. Dr. Anand is also affiliated with San Juan Regional Medical Center. The medical group on file is Four Corners Cancer Center / San Juan Oncology Associates, P.C. Dmand AI also links Dr. Anand to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anand practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Anand's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Anand is licensed in New Mexico.

CMS data shows 25,427 Medicare services from Dr. Anand across 33 procedure codes in 2024, for 276 Medicare patients. Medicare paid $313,798 for them. Every service was in an office.

CMS counts 276 Medicare patients who saw Dr. Anand in 2024. The largest group is 65 to 74, with 108 patients. 74% of them have high blood pressure, and 57% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Anand's median patient age at 69, with 60% women.

In 2024, Dr. Anand wrote 550 Medicare Part D claims for 108 patients. 76% of them were for generic drugs. CMS names the drug for 357 of them, across 14 drugs with 11 or more claims each, at $639,390 in total drug cost. In 2023, CMS named 482 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Anand for performance year 2024, reported as part of a group. Dr. Anand accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 23 papers to Dr. Anand, published from 2014 to 2024. 2017 was the busiest year, with 3. The most frequent topics are India, Carcinoma, Squamous Cell and Cesarean Section. Dr. Anand has published most often in Front Public Health. Dr. Anand's most frequent co-authors are Shrey Desai, MD, Pankaj Shah, MD, PS and Prathima R. Anandi, MD.

CMS Open Payments shows 243 general payments to Dr. Anand from 43 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 29% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $6,919.